| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1018347429 |
| P356 | DOI | 10.1385/MO:19:1:55 |
| P698 | PubMed publication ID | 12025891 |
| P50 | author | Natividad Neri | Q56697647 |
| P2093 | author name string | Martha González | |
| Agustin Avilés | |||
| Alejandra Talavera | |||
| Claudia Castañeda | |||
| Judith Huerta-Guzmán | |||
| P2860 | cites work | Pegylated doxorubicin for primary cutaneous T-cell lymphoma: a report on ten patients with follow-up | Q32054762 |
| Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group | Q33773306 | ||
| Autologous stem cell transplantation for malignancy: a systematic review of the literature | Q33904435 | ||
| Randomized comparative trial of pegylated liposomal doxorubicin versus bleomycin and vincristine in the treatment of AIDS-related Kaposi's sarcoma. International Pegylated Liposomal Doxorubicin Study Group | Q34745283 | ||
| Efficacy of pegylated-liposomal doxorubicin in the treatment of AIDS-related Kaposi's sarcoma after failure of standard chemotherapy | Q39458073 | ||
| Clinical impact of chemotherapy dose escalation in patients with hematologic malignancies and solid tumors | Q41562126 | ||
| Dose escalation of epirubicin in the CEOP-BLEO regimen: a controlled clinical trial comparing standard doses for the treatment of diffuse large cell lymphoma | Q44535648 | ||
| Phase II study of liposomal doxorubicin in refractory ovarian cancer: antitumor activity and toxicity modification by liposomal encapsulation. | Q45976411 | ||
| Treatment of advanced breast cancer with sterically stabilized liposomal doxorubicin: results of a multicenter phase II trial | Q59289264 | ||
| Adjuvant radiotherapy to sites of previous bulky disease in patients stage IV diffuse large cell lymphoma | Q71656488 | ||
| Correlation of toxicity with pharmacokinetics of pegylated liposomal doxorubicin (Doxil) in metastatic breast carcinoma | Q74240010 | ||
| Comparative study of the antitumor activity of free doxorubicin and polyethylene glycol-coated liposomal doxorubicin in a mouse lymphoma model | Q74360937 | ||
| The use of cardiac biopsy to demonstrate reduced cardiotoxicity in AIDS Kaposi's sarcoma patients treated with pegylated liposomal doxorubicin | Q77306436 | ||
| P433 | issue | 1 | |
| P921 | main subject | doxorubicin | Q18936 |
| chemotherapy | Q974135 | ||
| P304 | page(s) | 55-58 | |
| P577 | publication date | 2002-01-01 | |
| P1433 | published in | Medical Oncology | Q2152666 |
| P1476 | title | Pegylated liposomal doxorubicin in combination chemotherapy in the treatment of previously untreated aggressive diffuse large-B-cell lymphoma | |
| P478 | volume | 19 |
| Q52923724 | A phase I/IIa clinical trial of CLAOP21 and CLAOP14 in patients with high grade non-Hodgkins lymphoma. |
| Q46606526 | A phase II study of liposomal daunorubicin, in combination with cyclophosphamide, vincristine and prednisolone, in elderly patients with previously untreated aggressive non-Hodgkin lymphoma |
| Q28270920 | CHOP-rituximab with pegylated liposomal doxorubicin for the treatment of elderly patients with diffuse large B-cell lymphoma |
| Q38084826 | Drug conjugates such as Antibody Drug Conjugates (ADCs), immunotoxins and immunoliposomes challenge daily clinical practice. |
| Q33931886 | In vivo targeting of B-cell lymphoma with glycan ligands of CD22. |
| Q35595419 | Liposome-based approaches to overcome anticancer drug resistance |
| Q34470480 | Liposomes modified by carbohydrate ligands can target B cells for the treatment of B-cell lymphomas |
| Q35132483 | Pegylated liposomal doxorubicin replacing conventional doxorubicin in standard R-CHOP chemotherapy for elderly patients with diffuse large B-cell lymphoma: an open label, single arm, phase II trial |
| Q78778073 | Recent publications in hematological oncology |
| Q36511593 | Replacement of conventional doxorubicin by pegylated liposomal doxorubicin in standard RCHOP chemotherapy for elderly diffuse large B-Cell lymphoma: a retrospective study in China |
| Q53062088 | Rituximab plus liposomal pegylated doxorubicin in the treatment of primary cutaneous B-cell lymphomas. |
| Q35989968 | Tailored therapy in an unselected population of 91 elderly patients with DLBCL prospectively evaluated using a simplified CGA. |
| Q38190105 | The more patients you treat, the more you cure: managing cardiotoxicity in the treatment of aggressive non-Hodgkin lymphoma |
| Q36210937 | The role of pixantrone in the treatment of non-Hodgkin's lymphoma |
Search more.